vimarsana.com

Latest Breaking News On - Qingshan li - Page 1 : vimarsana.com

CStone Announces Oral Presentation at ESMO World GI 2023 for Pivotal Phase 3 Clinical Study of Sugemalimab in First-Line Esophageal Squamous Cell Carcinoma

China - CStone Pharmaceuticals , a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today. | June 13, 2023

vimarsana © 2020. All Rights Reserved.